Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors

European Journal of Pharmacology

Volumn 671, Issue 1-3, 2011, Pages 79-86

  Ueda, Takashi ^a   Ugawa, Shinya ^a   Ishida, Yusuke ^b   Shimada, Shoichi ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Aripiprazole; Dopamine D2L receptor partial agonist antagonist; Geissoschizine methyl ether; Serotonin 5 HT 7 receptor antagonist; Serotonin 5 HT1A receptor partial agonist; Serotonin 5 HT2A 2C receptor antagonist

Indexed keywords

ARIPIPRAZOLE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GEISSOSCHIZINE; GEISSOSCHIZINE METHYL ETHER; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HL-60 CELLS; HUMANS; INDOLES; MICE; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN;

EID: 80455160158     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.007     Document Type: Article

References (33)

1. 7 antagonist: relevance for antidepressant actions in vivo Psychopharmacology (Berl) 205 2009 119 128
2. D.J. Bill, M. Knight, E.A. Forster, and A. Fletcher Direct evidence for an important species difference in the mechanism of 8-OH-DPAT induced hypothermia Br. J. Pharmacol. 103 1991 1857 1864
3. 7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents J. Pharmacol. Exp. Ther. 321 2007 690 698 (Pubitemid 46624521)
4. 2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists Mol. Pharmacol. 70 2006 1956 1964 (Pubitemid 44771911)
5. 1A receptor as assessed with the cytosensor microphysiometer J. Pharmacol. Toxicol. Methods 40 1998 47 55 (Pubitemid 29062906)
6. 7 receptor antagonist, in mouse models predictive of antipsychotic-like activity Behav. Pharmacol. 19 2008 153 159 (Pubitemid 351365693)
7. S. Imamura, M. Tabuchi, H. Kushida, A. Nishi, H. Kanno, T. Yamaguchi, K. Sekiguchi, Y. Ikarashi, and Y. Kase The blood-brain barrier permeability of geissoschizine methyl ether in uncaria hook, a galenical constituent of the traditional Japanese medicine Yokukansan Cell. Mol. Neurobiol. 31 2011 787 793
8. K. Iwasaki, T. Satoh-Nakagawa, M. Maruyama, Y. Monma, M. Nemoto, N. Tomita, H. Tanji, H. Fujiwara, T. Seki, M. Fujii, H. Arai, and H. Sasaki A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients J. Clin. Psychiatry 66 2005 248 252 (Pubitemid 40314333)
9. K. Iwasaki, M. Maruyama, N. Tomita, K. Furukawa, M. Nemoto, H. Fujiwara, T. Seki, M. Fujii, M. Kodama, and H. Arai Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies J. Clin. Psychiatry 66 2005 1612 1613 (Pubitemid 43068707)
10. 1A receptor Eur. J. Pharmacol. 441 2002 137 140 (Pubitemid 34626163)
11. S. Jordan, J.L. Johnson, K. Regardie, R. Chen, V. Koprivica, Y. Tadori, J. Kambayashi, H. Kitagawa, and Y. Kikuchi Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 348 356 (Pubitemid 46209412)
12. 2Long receptor signalling J. Psychopharmacol. 21 2007 620 627 (Pubitemid 47472726)
13. C.P. Lawler, C. Prioleau, M.M. Lewis, C. Mak, D. Jiang, J.A. Schetz, A.M. Gonzalez, D.R. Sibley, and R.B. Mailman Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes Neuropsychopharmacology 20 1999 612 627 (Pubitemid 29189265)
14. 7) implicated in the regulation of mammalian circadian rhythms Neuron 11 1993 449 458 (Pubitemid 23287072)
15. 1A autoreceptor response and its evaluation as a model to selectively identify antidepressants Br. J. Pharmacol. 107 1992 15
16. H.Y. Meltzer The role of serotonin in antipsychotic drug action Neuropsychopharmacology 21 2 Suppl. 1999 106S 115S (Pubitemid 29396478)
17. M.J. Millan Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors J. Pharmacol. Exp. Ther. 295 2000 853 861
18. S. Miyamoto, G.E. Duncan, C.E. Marx, and J.A. Lieberman Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol. Psychiatry 10 2005 79 104 (Pubitemid 40139590)
19. T. Miyaoka, M. Furuya, H. Yasuda, M. Hayashia, T. Inagaki, and J. Horiguchi Yi-gan san for the treatment of borderline personality disorder: an open-label study Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 150 154
20. T. Miyaoka, M. Furuya, H. Yasuda, M. Hayashida, A. Nishida, T. Inagaki, and J. Horiguchi Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study Clin. Neuropharmacol. 32 2009 6 9
21. A. Monji, M. Takita, T. Samejima, T. Takaishi, K. Hashimoto, H. Matsunaga, M. Oda, Y. Sumida, Y. Mizoguchi, T. Kato, H. Horikawa, and S. Kanba Effect of Yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 308 311
22. H.A. Muntasir, J. Takahashi, M. Rashid, M. Ahmed, T. Komiyama, M. Hossain, J. Kawakami, M. Nashimoto, and T. Nagatomo Site-directed mutagenesis of the serotonin 5-hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding Biol. Pharm. Bull. 29 2006 1645 1650 (Pubitemid 44166367)
23. A. Newman-Tancredi The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives Curr. Opin. Investig. Drugs 11 2010 802 812
24. T. Pengsuparp, B. Indra, O. Nakagawasai, T. Tadano, Y. Mimaki, Y. Sashida, Y. Ohizumi, and K. Kisara Pharmacological studies of geissoschizine methyl ether, isolated from Uncaria sinensis Oliv., in the central nervous system Eur. J. Pharmacol. 425 2001 211 218 (Pubitemid 32770069)
25. D.A. Shapiro, S. Renock, E. Arrington, L.A. Chiodo, L.X. Liu, D.R. Sibley, B.L. Roth, and R. Mailman Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 2003 1400 1411 (Pubitemid 41070874)
26. H. Shinno, E. Utani, S. Okazaki, T. Kawamukai, H. Yasuda, T. Inagaki, Y. Inami, and J. Horiguchi Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 1543 1545 (Pubitemid 47302569)
27. H. Shinno, M. Kamei, Y. Nakamura, Y. Inami, and J. Horiguchi Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1749 1751
28. 2S receptors render it a unique antipsychotic Eur. J. Pharmacol. 515 2005 10 19 (Pubitemid 40779262)
29. 2 receptors Eur. J. Pharmacol. 607 2009 35 40
30. K. Terawaki, Y. Ikarashi, K. Sekiguchi, Y. Nakai, and Y. Kase Partial agonistic effect of Yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells J. Ethnopharmacol. 127 2010 306 312
31. T. Ueda, S. Ugawa, Y. Ishida, A. Hondoh, and S. Shimada Development of generic calcium imaging assay for monitoring Gi-coupled receptors and G-protein interaction J. Biomol. Screen. 14 2009 781 788
32. 2 receptor-mediated signaling pathways Neuropsychopharmacology 32 2007 67 77 (Pubitemid 44967785)
33. 2 receptor, but the rodent metabolite displays antagonist properties Eur. J. Pharmacol. 546 2006 88 94 (Pubitemid 44339632)